More than 14 billion doses (including 2020 doses) are planned for 2021, enough for six billion individuals—assuming that all innovators’ vaccines are successful and require two doses.
To read the article, see “On pins and needles: Tracking COVID-19 vaccines and therapeutics,” February 18, 2021.